Psyence Biomedical Ltd. (PBM) Retained Earnings (2023 - 2026)

Psyence Biomedical's Retained Earnings history runs 4 years deep, the most recent figure standing at -$63.4 million for Q1 2026.

• In Q1 2026, Retained Earnings fell 12.29% year-over-year to -$63.4 million; the TTM figure through Mar 2026 stood at -$63.4 million (down 12.29% YoY), while the FY2026 annual figure was -$63.4 million, down 12.29% from the prior year.
• Retained Earnings for Q1 2026 stood at -$63.4 million, down from $347253.0 in the prior quarter.
• The five-year high for Retained Earnings was $1.7 million in Q1 2023, with the low at -$16069.5 billion in Q3 2023.
• The 4-year median for Retained Earnings is -$54.5 million (2024), against an average of -$2295.7 billion.
• Peak annual rise in Retained Earnings reached 100.64% in 2025, while the deepest fall reached 15733.88% in 2025.
• Psyence Biomedical's Retained Earnings stood at -$16069.5 billion in 2023, then surged by 100.0% to -$54.5 million in 2024, then jumped by 100.64% to $347253.0 in 2025, then slumped by 18352.87% to -$63.4 million in 2026.
• Business Quant data shows PBM's Retained Earnings at -$63.4 million in Q1 2026, $347253.0 in Q3 2025, and -$56.4 million in Q1 2025.